The Coherex WaveCrest is the latest development in left atrial appendage occlusion.

The WaveCrest device is uniquely designed to improve confidence in clinical outcomes through:

  • Control of placement with retractable anchors
  • Visualization of acute closure, position, and stability
  • Rapid endothelization

Coherex has received CE Mark approval for the WaveCrest and expects to begin commercialization outside the US immediately.

Plans are underway to conduct clinical trials leading to regulatory approval in the USA and Japan.

Click here to read more about the device.